1. Home
  2. REBN vs LIXT Comparison

REBN vs LIXT Comparison

Compare REBN & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REBN
  • LIXT
  • Stock Information
  • Founded
  • REBN 2015
  • LIXT 2005
  • Country
  • REBN United States
  • LIXT United States
  • Employees
  • REBN N/A
  • LIXT N/A
  • Industry
  • REBN Restaurants
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • REBN Consumer Discretionary
  • LIXT Health Care
  • Exchange
  • REBN Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • REBN 15.3M
  • LIXT 12.4M
  • IPO Year
  • REBN 2022
  • LIXT N/A
  • Fundamental
  • Price
  • REBN $2.52
  • LIXT $5.44
  • Analyst Decision
  • REBN
  • LIXT
  • Analyst Count
  • REBN 0
  • LIXT 0
  • Target Price
  • REBN N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • REBN 89.9K
  • LIXT 167.8K
  • Earning Date
  • REBN 08-14-2025
  • LIXT 11-11-2025
  • Dividend Yield
  • REBN N/A
  • LIXT N/A
  • EPS Growth
  • REBN N/A
  • LIXT N/A
  • EPS
  • REBN N/A
  • LIXT N/A
  • Revenue
  • REBN $6,565,623.00
  • LIXT N/A
  • Revenue This Year
  • REBN $335.98
  • LIXT N/A
  • Revenue Next Year
  • REBN N/A
  • LIXT N/A
  • P/E Ratio
  • REBN N/A
  • LIXT N/A
  • Revenue Growth
  • REBN 14.03
  • LIXT N/A
  • 52 Week Low
  • REBN $1.03
  • LIXT $0.64
  • 52 Week High
  • REBN $8.30
  • LIXT $6.26
  • Technical
  • Relative Strength Index (RSI)
  • REBN 44.40
  • LIXT 61.94
  • Support Level
  • REBN $2.33
  • LIXT $5.40
  • Resistance Level
  • REBN $2.89
  • LIXT $6.26
  • Average True Range (ATR)
  • REBN 0.18
  • LIXT 0.61
  • MACD
  • REBN 0.01
  • LIXT 0.10
  • Stochastic Oscillator
  • REBN 36.25
  • LIXT 65.55

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: